These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23605140)

  • 1. Theoretical studies of structure, energetics and properties of Ca²⁺ complexes with alizarin glucoside.
    Toczek D; Kubas K; Turek M; Roszak S; Gancarz R
    J Mol Model; 2013 Oct; 19(10):4209-14. PubMed ID: 23605140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of glycoside derivatives of hydroxyanthraquinone with ability to dissolve and inhibit formation of crystals of calcium oxalate. Potential compounds in kidney stone therapy.
    Frackowiak A; Skibiński P; Gaweł W; Zaczyńska E; Czarny A; Gancarz R
    Eur J Med Chem; 2010 Mar; 45(3):1001-7. PubMed ID: 20005021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsolvation and hydration enthalpies of CaC₂O₄(H₂O) n (n=0-16) and C₂O₄²⁻(H₂O) n (n=0-14): an ab initio study.
    Rosas-García VM; del Carmen Sáenz-Tavera I; Rodríguez-Herrera VJ; Garza-Campos BR
    J Mol Model; 2013 Apr; 19(4):1459-71. PubMed ID: 23232865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium oxalate: calcium phosphate transformations.
    Nancollas GH; Henneman ZJ
    Urol Res; 2010 Aug; 38(4):277-80. PubMed ID: 20625892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular modifiers reveal a mechanism of pathological crystal growth inhibition.
    Chung J; Granja I; Taylor MG; Mpourmpakis G; Asplin JR; Rimer JD
    Nature; 2016 Aug; 536(7617):446-50. PubMed ID: 27501150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new compound in kidney stones? Powder X-ray diffraction study of calcium glycinate trihydrate.
    Le Bail A; Daudon M; Bazin D
    Acta Crystallogr C; 2013 Jul; 69(Pt 7):734-7. PubMed ID: 23832032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual roles of brushite crystals in calcium oxalate crystallization provide physicochemical mechanisms underlying renal stone formation.
    Tang R; Nancollas GH; Giocondi JL; Hoyer JR; Orme CA
    Kidney Int; 2006 Jul; 70(1):71-8. PubMed ID: 16641926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antioxidant Activity of Quercetin and Its Glucosides from Propolis: A Theoretical Study.
    Zheng YZ; Deng G; Liang Q; Chen DF; Guo R; Lai RC
    Sci Rep; 2017 Aug; 7(1):7543. PubMed ID: 28790397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemolysis of calcium oxalate stones: study in vitro and possible clinical application.
    Kustov AV; Shevyrin AA; Strel'nikov AI; Smirnov PR; Trostin VN
    Urol Res; 2012 Jun; 40(3):205-9. PubMed ID: 22089056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial Synthesis of Non-Natural Anthraquinone Glucosides Displaying Superior Antiproliferative Properties.
    Nguyen TTH; Pandey RP; Parajuli P; Han JM; Jung HJ; Park YI; Sohng JK
    Molecules; 2018 Aug; 23(9):. PubMed ID: 30154376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium oxalate monohydrate renal calculi. Formation and development mechanism.
    Söhnel O; Grases F
    Adv Colloid Interface Sci; 1995 Aug; 59():1-17. PubMed ID: 7576314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geobiology reveals how human kidney stones dissolve in vivo.
    Sivaguru M; Saw JJ; Williams JC; Lieske JC; Krambeck AE; Romero MF; Chia N; Schwaderer AL; Alcalde RE; Bruce WJ; Wildman DE; Fried GA; Werth CJ; Reeder RJ; Yau PM; Sanford RA; Fouke BW
    Sci Rep; 2018 Sep; 8(1):13731. PubMed ID: 30213974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of crystal surface adhesion in kidney stone disease.
    Wesson JA; Ward MD
    Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):386-93. PubMed ID: 16775453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro effects on calcium oxalate crystallization kinetics and crystal morphology of an aqueous extract from Ceterach officinarum: Analysis of a potential antilithiatic mechanism.
    De Bellis R; Piacentini MP; Meli MA; Mattioli M; Menotta M; Mari M; Valentini L; Palomba L; Desideri D; Chiarantini L
    PLoS One; 2019; 14(6):e0218734. PubMed ID: 31238335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular modulation of calcium oxalate crystallization.
    De Yoreo JJ; Qiu SR; Hoyer JR
    Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1123-31. PubMed ID: 17082348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal surface adhesion explains the pathological activity of calcium oxalate hydrates in kidney stone formation.
    Sheng X; Ward MD; Wesson JA
    J Am Soc Nephrol; 2005 Jul; 16(7):1904-8. PubMed ID: 15930089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peeping into human renal calcium oxalate stone matrix: characterization of novel proteins involved in the intricate mechanism of urolithiasis.
    Aggarwal KP; Tandon S; Naik PK; Singh SK; Tandon C
    PLoS One; 2013; 8(7):e69916. PubMed ID: 23894559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR
    J Am Soc Nephrol; 2005 Feb; 16(2):417-24. PubMed ID: 15647340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Citrate salts for calcium containing kidney stones : Prevention and treatment].
    Wilhelm K
    Urologe A; 2016 Nov; 55(11):1487-1490. PubMed ID: 27637183
    [No Abstract]   [Full Text] [Related]  

  • 20. [XRD, FTIR and thermoluminescence spectra of different types of urinary stones].
    Yang J; He JY; Ouyang JM
    Guang Pu Xue Yu Guang Pu Fen Xi; 2011 Aug; 31(8):2268-73. PubMed ID: 22007431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.